CMB.AX · CAMBIUM BIO LIMITED
Australia · RS rating 75 · As of 2026-10-14
| Price | 0.45 AUD |
|---|---|
| 1-day change | -16.7% |
| RS rating (overall / 1M / 3M / 12M) | 75 / 56 / 76 / 67 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 43 / 10 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +25.0% |
| Market cap (USD) | $11.1M |